Category

Daily Briefs

Daily Brief Health Care: Ming Yu Pharmaceutical, Celltrion Inc, Eli Lilly & Co, Kymera Therapeutics , Lumexa Imaging Holdings, MetaVia, Mirum Pharmaceuticals, Physiomics, Cardiff Oncology, UEM Edgenta Bhd and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Ming Yu Pharmaceutical (明宇制药) Pre-IPO Quick Comment: Meaningful Improvement to Incumbents
  • Celltrion (068270 KS): Stellar 3Q Result; Poised for Accelerated Growth on Expanding Portfolio
  • Eli Lilly’s Adverum Acquisition: What They Didn’t Say in the Press Release!
  • Kymera Therapeutics Surges 46%: A New Oral Challenger To Dupixent?
  • Lumexa Imaging Holdings, Inc. (LMRI): Steady IPO Debut for Imaging Company
  • MTVA: New Date for Vanoglipel (DA-1241) Presented at AASLD
  • Mirum Pharma’s $620M Bluejay Acquisition: Strategic Masterstroke or High-Stakes Misfire?
  • Hybridan Small Cap Feast: 4 December 2025
  • CRDF: Initiating Coverage – Combination Therapy Elicits Superior Response
  • Primer: UEM Edgenta Bhd (UEME MK) – Dec 2025


Ming Yu Pharmaceutical (明宇制药) Pre-IPO Quick Comment: Meaningful Improvement to Incumbents

By Ke Yan, CFA, FRM

  • Ming Yu, a China-based clinical-stage biotech company, is looking to raise at least USD 100 million via a Hong Kong listing. MS, BOA, and CITIC are the joint book runners.
  • In this note, we look at the company’s core products, MHB018A and MHB036C, and assess the selling point around the core product.
  • We also look at the company’s pre-IPO investors and management team.

Celltrion (068270 KS): Stellar 3Q Result; Poised for Accelerated Growth on Expanding Portfolio

By Tina Banerjee

  • Celltrion Inc (068270 KS) has reported 3Q25 result, with double-digit YoY growth in key parameters. Key parameters also improved sequentially. Stellar 3Q performance was powered by high-margin young products.
  • In 4Q25, Celltrion is expected to achieve sequential revenue growth of at least 30%, the COGS ratio in the mid- 30% range, and the operating profit margin improving to 40%.
  • Stable revenue from mature products and rapid growth from newly launched products should drive topline growth. With the merger effect ending in 3Q25, profitability should improve in 4Q.

Eli Lilly’s Adverum Acquisition: What They Didn’t Say in the Press Release!

By Baptista Research

  • Eli Lilly isn’t slowing down.
  • After a quarter filled with blockbuster drug launches, accelerated global uptake of Mounjaro and Zepbound, and $12 billion in quarterly product revenue, the pharma heavyweight has turned its attention to gene therapy.
  • The Eli Lilly Adverum acquisition is now official, as announced on December 9, 2025.

Kymera Therapeutics Surges 46%: A New Oral Challenger To Dupixent?

By Baptista Research

  • Kymera Therapeutics surged as much as 46% to a record high of $97.28 after announcing highly encouraging Phase 1b clinical data for its anti-inflammatory drug candidate, KT-621.
  • The once-daily oral pill demonstrated significant reductions in key Type 2 inflammation biomarkers, including STAT6 and fractional exhaled nitric oxide (FeNO), and was well-tolerated with a favorable safety profile.
  • These early findings have sparked investor enthusiasm, especially as KT-621 shows potential to rival injectable therapies like Regeneron’s Dupixent.

Lumexa Imaging Holdings, Inc. (LMRI): Steady IPO Debut for Imaging Company

By IPO Boutique

  • Lumexa priced 25mm shares at $18.50 and delivered a stable debut, reflecting disciplined valuation despite broad 2025 weakness in PE-backed IPOs.
  • Strong oversubscription from long-only and healthcare-dedicated investors supported a solid open, with first-day trading remaining orderly and tightly ranged.
  • Lumexa’s scaled outpatient imaging platform, strong payer mix, and superior margins position it favorably within a fragmented $140B market with substantial consolidation runway.

MTVA: New Date for Vanoglipel (DA-1241) Presented at AASLD

By Zacks Small Cap Research

  • In November 2025, MetaVia Inc. (MTVA) announced new positive data from the Phase 2a clinical trial of vanoglipel (DA-1241) was presented at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting 2025.
  • After 16 weeks of treatment, vanoglipel showed reductions in HbA1c of 0.37%, 0.41%, and 0.54% at weeks 4, 8, and 16, from a baseline of 6.99%.
  • Vanoglipel also significantly decreased plasma ALT levels in subjects with baseline ALT between 40 and 200 U/L.

Mirum Pharma’s $620M Bluejay Acquisition: Strategic Masterstroke or High-Stakes Misfire?

By Baptista Research

  • Mirum Pharmaceuticals is making big moves.
  • In early December 2025, the company announced its plan to acquire privately held Bluejay Therapeutics in a deal worth up to $820 million.
  • The proposed transaction includes $250 million in cash, $370 million in Mirum common stock, and up to $200 million in tiered sales-based milestones.

Hybridan Small Cap Feast: 4 December 2025

By Hybridan

  • Alien Metals 0.125p £11.6m (UFO.L) The minerals exploration and development company has reported that its joint venture partner, West Coast Silver Limited has announced that it has entered into a non-binding Memorandum of Understanding with Artemis Resources Limited to evaluate the potential for Artemis’ Radio Hill Processing Plant, located near Karratha, to process material sourced from West Coast’s Elizabeth Hill Silver Mine in the Pilbara.
  • Digitalbox 4.75p £5.6m (DBOX.L) The mobile-first digital media business, with websites such as the Entertainment Daily, The Daily Mash, The Poke, The Tab and TV Guide updates on its Q4 period in 2025.
  • The Company expects EBITDA for the FY December 2025 to be significantly ahead of expectations while revenue to be broadly in line. 

CRDF: Initiating Coverage – Combination Therapy Elicits Superior Response

By Zacks Small Cap Research

  • Cardiff is a clinical-stage, oncology-focused biotechnology company developing onvansertib against solid tumors including subsets of colorectal (CRC), pancreatic, lung and breast cancers.
  • The company’s primary indication is first line metastatic CRC in patients with Rat Sarcoma (RAS) mutations.
  • Onvansertib is an oral Polo-like kinase 1 (PLK1)-selective inhibitor that has synergies with bevacizumab & various chemotherapy regimens.

Primer: UEM Edgenta Bhd (UEME MK) – Dec 2025

By αSK

  • Strong International Growth and Order Book: UEM Edgenta is successfully executing a strategy of international expansion, with over 90% of new contracts in 1H 2024 originating from Singapore, Taiwan, and the Middle East. This has bolstered its total order book to RM9.3 billion as of March 2025, providing significant revenue visibility.
  • Resilient Business Model Amidst Margin Pressures: Despite recent quarterly losses attributed to higher operational costs and cyclical factors, the company demonstrates resilience through its diversified service offerings and long-term contracts, particularly in the essential healthcare and infrastructure sectors. Management expects a return to profitability driven by new contract contributions and cost management initiatives.
  • Attractive Valuation with Turnaround Potential: The company trades at a significant discount to peers on key metrics like EV/Sales and EV/EBITDA. While recent earnings volatility is a concern, the combination of a robust order book, a strategic focus on technology and international growth, and a formal cost-saving program presents a compelling turnaround narrative.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: AU Small Finance Bank Limited, Toyota Industries, SK Square , Raksul Inc, Hainan Meilan International Airport, Predictive Discovery, Aditya Birla Capital Ltd, Isupetasys and more

By | Daily Briefs, Most Read

In today’s briefing:

  • AU Small Finance Bank (AUBANK IN): Increased FOL & Large Passive Flows/ Impact
  • Toyota Industries (6201 JP): Elliott Ramps up the Pressure
  • Hynix & Square L2 Flags Set to Squeeze Spread Near Term
  • [Japan M&A] CEO & Chairman Entice GS to Sponsor an MBO for Recently Lackluster Raksul (4384)
  • Raksul (4384 JP): GS-Sponsored MBO at JPY1,710
  • Meilan Airport (357 HK)’s SPA (Finally) Done. Now For The HK$10.62/Share MGO
  • Predictive (PDI AU) & Robex (RBX AU) Together Again
  • NIFTY200 Momentum30 Index Rebalance: Huge Turnover and Flow in December
  • KOSPI200 Index Rebalances – A Year in Review (2025)
  • Predictive Discovery (PDI AU): Is Robex’s Revised Offer Really a Superior Proposal?


AU Small Finance Bank (AUBANK IN): Increased FOL & Large Passive Flows/ Impact

By Brian Freitas

  • AU Small Finance Bank Limited (AUBANK IN) has received approval from the Ministry of Finance to increase its Foreign Ownership Limit from 49% to 74% (the maximum permitted).
  • The increased FOL will result in passive inflows from global index trackers in February and March. The inflows are multiple days of ADV.
  • There has been little increase in positioning. The increased Foreign Ownership Limit and the passive flows to come could lead to the stock moving higher over the next few weeks.

Toyota Industries (6201 JP): Elliott Ramps up the Pressure

By Arun George

  • Elliott has filed a substantial shareholder notice reporting a Toyota Industries (6201 JP) ownership of 16.3 million or 5.01% of outstanding shares.
  • The disclosure is likely a tactic to pressure Toyota Fudosan (offeror) and also a useful signalling tactic to other minorities that Elliott is committed to securing a bump.
  • A potential bump could reach JPY19,000. While this would require an additional US$4 billion, financing should not be an issue as the book value (understated) is close to JPY18,000. 

Hynix & Square L2 Flags Set to Squeeze Spread Near Term

By Sanghyun Park

  • SK Hynix and SK Square hit L2 flags; cash-only until Dec 24. Margin off, >40% two-day rip triggers halt. L2 lifts if below T-5/+45%, T-15/+75%, and 15-day high.
  • L2’s usually a non-event, but this time the margin freeze probably smacks Hynix harder. Key trigger is staying below the 15-day high: Hynix ₩587,000, Square ₩324,000.
  • Govt set to roll out AI-semiconductor holdco deregulation this week, boosting AI holdcos like Square and juicing a near-term Square-over-Hynix trade opportunity.

[Japan M&A] CEO & Chairman Entice GS to Sponsor an MBO for Recently Lackluster Raksul (4384)

By Travis Lundy

  • Raksul Inc (4384 JP) is a business roll-up business. They do printing, and advertising, and marketing, and supply. They want to be all things to all SMEs. 
  • They are pretty good at it. Revenues and EBIT have been growing at 20-30% a year for years, and are scheduled to grow 19% and 26% for several years ahead.
  • The bid is up 40% from last, but that gets them to a 30-month high. The register is very open. Lots of active institutional shareholders who have to agree. Maybe.

Raksul (4384 JP): GS-Sponsored MBO at JPY1,710

By Arun George

  • Raksul Inc (4384 JP) has recommended a Goldman Sachs Group (GS US)-sponsored MBO at JPY1,710, a 39.5% premium to the last close.
  • While the process is lacking (no auction), the offer is reasonable compared to peer multiples, analyst price targets and historical trading ranges. 
  • The offer aligns with the midpoint of the target IFA DCF valuation range. Barring an emergence of an activist, this should get done. 

Meilan Airport (357 HK)’s SPA (Finally) Done. Now For The HK$10.62/Share MGO

By David Blennerhassett

  • Given the change of control into Meilan Airport (357 HK), was, in effect, a  re-arrangement of Meilan Airport shares under the same ultimate parent, the regulatory approval process curiously dragged.
  • Yesterday Meilan Airport announced all SPA conditions have now been satisfied, and that the SPA should complete in 20 business days. A Composite Doc will then be issued.
  • Trading almost at terms. This is a back-end proposition play. My peer basket is up 11%, on average, since the Offer was first announced. Asian peers are up 15%.

Predictive (PDI AU) & Robex (RBX AU) Together Again

By David Blennerhassett

  • After Perseus Mining (PRU AU) fielded a scrip option for 17.8%-held Predictive Discovery (PDI AU), I questioned whether Robex Resources (RXR AU) would exercise its matching rights. I was wrong. 
  • Robex has “lifted its bid“, now 7.862 PDI for every Robex share. Under the revised Offer Robex will own 46.5% of the combined entity, down from 49%.
  • PDI considers the new terms to be superior to Perseus’ tilt. Apparently, so do several of PDI’s largest shareholders.  Perseus has now terminated its binding proposal. Out of the picture?

NIFTY200 Momentum30 Index Rebalance: Huge Turnover and Flow in December

By Brian Freitas

  • There will be 19 constituent changes for the Nifty200 Momentum 30 Index that will be implemented at the close on 30 December.
  • Estimated one-way turnover is 64.6% resulting in a round-trip trade of INR 161.3bn (US$1.8bn). There are 27 stocks with over 1x ADV to trade.
  • Some stocks will have passive flows from other index trackers at the same time while others are potential adds/close adds to global indices over the next couple of months.

KOSPI200 Index Rebalances – A Year in Review (2025)

By Douglas Kim

  • In this insight, we discuss the price performance actions of 32 stocks that have been rebalanced in KOSPI200 in 2025.
  • Among the 16 additions to the KOSPI200 index in 2025, the average share price performances are up on average 19.5% (3 months performance prior to the announcement dates).
  • Among the 16 deletions to the KOSPI200 index in 2025, the average share price performances are down on average 13.5% (3 months performance prior to the announcement dates).

Predictive Discovery (PDI AU): Is Robex’s Revised Offer Really a Superior Proposal?

By Arun George

  • Under the revised merger terms, Robex Resources (RBX CN) shareholders would receive 7.862 Predictive Discovery (PDI AU) shares per Robex share (vs 8.667 previously). PDI shareholders get 53.5% of MergerCo.
  • The Board has declared that Robex’s offer is superior to the Perseus scheme’s offer. Strangely, on a value basis, the Robex revised offer is still lower than the Perseus offer.
  • Robex’s offer is mainly superior due to support from major PDI shareholders, who reportedly oppose a Perseus Mining (PRU AU) scheme, thereby lowering the likelihood of a revised Perseus offer. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief Japan: Toyota Industries, Iino Kaiun Kaisha, Nippon Aqua, Lifenet Insurance Company, Toyota Motor, Seven & I Holdings, Santen Pharmaceutical, Toho Gas Co Ltd, Renaissance Inc, IBJ and more

By | Daily Briefs, Japan

In today’s briefing:

  • Toyota Industries (6201 JP): Elliott Ramps up the Pressure
  • IINO Kaiun Kaisha (9119 JP) – Navigating the Cycle with Structural Resilience
  • Q3 Follow-Up: Nippon Aqua (1429 JP) – November 28, 2025
  • LIFENET INSURANCE COMPANY (7157 JP) – Strategic Clarity on the Path to Growth
  • Toyota Motor (7203 JP) Tactical Outlook: Undervalued and Rising
  • Seven Eleven: Still a Work in Progress as Lawson and Familymart Innovate
  • Santen Pharmaceutical (4536 JP): Sequential Improvement, Guidance Reiterated, Better H2 Anticipated
  • (09 Dec 2025) Toho Gas Co Ltd(9533 JP) — Fisco Company Research
  • Primer: Renaissance Inc (2378 JP) – Dec 2025
  • IBJ (6071 JP) – Diversification Taking Shape


Toyota Industries (6201 JP): Elliott Ramps up the Pressure

By Arun George

  • Elliott has filed a substantial shareholder notice reporting a Toyota Industries (6201 JP) ownership of 16.3 million or 5.01% of outstanding shares.
  • The disclosure is likely a tactic to pressure Toyota Fudosan (offeror) and also a useful signalling tactic to other minorities that Elliott is committed to securing a bump.
  • A potential bump could reach JPY19,000. While this would require an additional US$4 billion, financing should not be an issue as the book value (understated) is close to JPY18,000. 

IINO Kaiun Kaisha (9119 JP) – Navigating the Cycle with Structural Resilience

By Astris Advisory Japan

  • The somewhat unexpected outperformance in H1 FY3/26 reflects the volatile nature of the shipping industry, and the impact of macro events.
  • The stability provided by the Real Estate segment remains a key enabler for IINO Lines’ long-term strategy.
  • With a conservative D/E ratio of 0.79x, the Company retains significant financial flexibility to withstand shipping cycle volatility while funding its capital- intensive fleet renewal program. 

Q3 Follow-Up: Nippon Aqua (1429 JP) – November 28, 2025

By Sessa Investment Research

  • Japan’s leading on-site urethane foam insulation installer with strong growth Nippon Aqua Co., Ltd. (hereinafter, the Company) is a high-growth enterprise listed on the Prime Market of the Tokyo Stock Exchange.
  • Guided by its management philosophy— “Contribution to society through the creation of living environments that are friendly to people and the earth”—the Company leverages insulation and waterproofing technologies to drive energy efficiency and support a sustainable society.
  • It holds the leading domestic share in on-site urethane foam insulation installation and operates its business through three key divisions: Single-family homes, Buildings, and Waterproofing.

LIFENET INSURANCE COMPANY (7157 JP) – Strategic Clarity on the Path to Growth

By Astris Advisory Japan

  • H1 FY3/26 results demonstrated solid execution, highlighted by visible efficiency gains.
  • We believe visibility toward growth acceleration has improved post- Q2; the recovery in Individual Life is gaining momentum, evidenced by accelerating AP growth and improved profitability from tech- driven efficiency initiatives.
  • Furthermore, the new partnership with The Kyoto Shinkin Bank clarifies the GCL segment’s growth upside by opening a strategic pathway to the vast domestic bank mortgage market. 

Toyota Motor (7203 JP) Tactical Outlook: Undervalued and Rising

By Nico Rosti

  • On October 21st we published an insight predicting Toyota Motor’s imminent pullback. The stock started to pullback the following week, the correction lasted for a few weeks.
  • After last week’s weakness, Toyota Motor (7203 JP) is rallying again. There’s conflicting sentiment on valuation—some see it as undervalued.
  • This insight presents a short-term tactical analysis with a bullisht target at 3291 (75% probability of seeing a new pullback after that target is reached). 

Seven Eleven: Still a Work in Progress as Lawson and Familymart Innovate

By Michael Causton

  • The convenience store sector is not only saturated but also facing serious levels of new competition. Despite this, Seven Eleven posted much higher growth in November but problems remain.
  • The big 3 are working hard to innovate their way out of trouble and move on to new, fertile pastures of growth but Seven Eleven is behind Lawson and Familymart.
  • Innovation means high levels of differentiation across prices, tech, services and merchandising, making each chain much more distinctive and a fascinating example of where Japanese retail is headed.

Santen Pharmaceutical (4536 JP): Sequential Improvement, Guidance Reiterated, Better H2 Anticipated

By Tina Banerjee

  • Santen Pharmaceutical (4536 JP) witnessed revenue drop with profits also declining in H1FY26. Sequential quarterly improvement a positive. EMEA and Asia grow driving the overseas business rise.
  • Company reiterated FY26 guidance where revenue is projected at ¥294B (down 2% YoY) and core operating profit at ¥54B (down 9% YoY). H2FY26 expected to be strong.
  • Regular drug development, consistent approvals for new indications coupled with licensing deals and its market leadership position will help Santen to see through the sluggishness.

(09 Dec 2025) Toho Gas Co Ltd(9533 JP) — Fisco Company Research

By FISCO

Key points (machine generated)

  • Toho Gas reported increased revenue and profit for the interim period of fiscal year ending March 2026 due to rising customer numbers.
  • The company, celebrating its 100th anniversary in 2022, has transitioned from coal to oil and now to natural gas, becoming a top player in the urban gas sector.
  • Toho Gas is committed to community contributions, focusing on building trust and enhancing quality of life.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only.


Primer: Renaissance Inc (2378 JP) – Dec 2025

By αSK

  • Renaissance Inc. is a major player in the Japanese fitness industry, demonstrating a strong revenue recovery post-pandemic, although profitability and cash flow remain volatile.
  • The company is diversifying its business model beyond traditional fitness clubs to include healthcare-related services, such as corporate wellness programs and senior-focused rehabilitation centers, tapping into Japan’s key demographic trends.
  • While facing intense competition and economic sensitivity, the company’s strategic focus on health solutions for an aging population and its established brand presence of over 100 clubs position it for potential long-term growth in the expanding wellness market.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


IBJ (6071 JP) – Diversification Taking Shape

By Astris Advisory Japan

  • Q1–3 FY12/25 results outperformed expectations. Membership in the core matchmaking business continued to grow steadily.
  • The Life Design segment also delivered significant growth, driven by solid performance in the photo, insurance, and wedding businesses, as well as the positive contribution from GROWBING, which was newly consolidated.
  • Organic growth continued to be a major driver of the group’s overall performance. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: Yixin Group , AU Small Finance Bank Limited, SK Hynix, Toyota Industries, Makino Milling Machine Co, Strategy, SK Square , Predictive Discovery, Hainan Meilan International Airport and more

By | Daily Briefs, Most Read

In today’s briefing:

  • CSI Hong Kong Connect Internet Index Rebalance: Large Flows & Impact on Friday
  • AU Small Finance Bank (AUBANK IN): Increased FOL & Large Passive Flows/ Impact
  • More Detailed Insight into Hynix’s Internal Situation Regarding the ADR Issue
  • Toyota Industries (6201 JP): Elliott Ramps up the Pressure
  • Makino Milling Machine (6135 JP): Tender Offer Risk/Reward
  • Strategy (MSTR US)’s Bitcoin Premium Evaporates. And Then Some
  • Hynix & Square L2 Flags Set to Squeeze Spread Near Term
  • Predictive (PDI AU) & Robex (RBX AU) Together Again
  • Meilan Airport (357 HK)’s SPA (Finally) Done. Now For The HK$10.62/Share MGO
  • Meilan Airport (357 HK): SPA Precondition Satisfied, Setting up an Unconditional MGO at HK$10.62


CSI Hong Kong Connect Internet Index Rebalance: Large Flows & Impact on Friday

By Brian Freitas

  • There are 2 constituent changes for the CSI Hong Kong Connect Internet Index in December. Plus there are large capping changes for some stocks.
  • Estimated one-way turnover at the rebalance is 11.9% and the round-trip trade is HK$26.6bn (US$3.4bn). There are 16 stocks with more than 1x ADV to trade.
  • The adds drifted lower vs the deletes in September and October but have started outperforming in December. There could be more outperformance following announcement of the index changes.

AU Small Finance Bank (AUBANK IN): Increased FOL & Large Passive Flows/ Impact

By Brian Freitas

  • AU Small Finance Bank Limited (AUBANK IN) has received approval from the Ministry of Finance to increase its Foreign Ownership Limit from 49% to 74% (the maximum permitted).
  • The increased FOL will result in passive inflows from global index trackers in February and March. The inflows are multiple days of ADV.
  • There has been little increase in positioning. The increased Foreign Ownership Limit and the passive flows to come could lead to the stock moving higher over the next few weeks.

More Detailed Insight into Hynix’s Internal Situation Regarding the ADR Issue

By Sanghyun Park

  • They’re maxing out M15X ahead of schedule, facing a fab gap until ’27, and now need more capex than their KRW 28tn cash pile comfortably covers.
  • SK doesn’t want an Hynix ADR; they’re focused on tapping the KRW 150tn Growth Fund to fill the capex gap while avoiding dilution and protecting their already-fragile control stack.
  • ADR noise spiked because Hynix’s near-term capex needs exceed Growth Fund capacity, pushing them toward a 2.4% treasury dump—but I still don’t see SK pulling the ADR trigger.

Toyota Industries (6201 JP): Elliott Ramps up the Pressure

By Arun George

  • Elliott has filed a substantial shareholder notice reporting a Toyota Industries (6201 JP) ownership of 16.3 million or 5.01% of outstanding shares.
  • The disclosure is likely a tactic to pressure Toyota Fudosan (offeror) and also a useful signalling tactic to other minorities that Elliott is committed to securing a bump.
  • A potential bump could reach JPY19,000. While this would require an additional US$4 billion, financing should not be an issue as the book value (understated) is close to JPY18,000. 

Makino Milling Machine (6135 JP): Tender Offer Risk/Reward

By Arun George

  • Makino Milling Machine Co (6135 JP)’s pre-conditional tender offer from MBK Partners is at JPY11,751 per share. The gross spread has increased to 9.9% due to several concerns.
  • The wide gross spread reflects the risk in satisfying the precondition, the fallout from the Homeplus saga and breaching the long stop date (16 January 2026).
  • While these concerns have merit, there are mitigating factors. The risk/reward is favourable as the upside (9.9% spread) exceeds the downside (6.3% to my estimated deal break price). 

Strategy (MSTR US)’s Bitcoin Premium Evaporates. And Then Some

By David Blennerhassett

  • Strategy (MSTR US)‘s market cap has for near-on five years, traded at a premium to its bitcoin holdings. 
  • The backbone of Strategy’s levered strategy is issue new shares or debt, acquire more bitcoins, which in turn, boost the share price. Rinse and repeat. Until the music stops.
  • That market cap is now at its widest discount in five years. And chairman Michael Saylor scandalously mooted the company may sell some bitcoins IF the discount persists.

Hynix & Square L2 Flags Set to Squeeze Spread Near Term

By Sanghyun Park

  • SK Hynix and SK Square hit L2 flags; cash-only until Dec 24. Margin off, >40% two-day rip triggers halt. L2 lifts if below T-5/+45%, T-15/+75%, and 15-day high.
  • L2’s usually a non-event, but this time the margin freeze probably smacks Hynix harder. Key trigger is staying below the 15-day high: Hynix ₩587,000, Square ₩324,000.
  • Govt set to roll out AI-semiconductor holdco deregulation this week, boosting AI holdcos like Square and juicing a near-term Square-over-Hynix trade opportunity.

Predictive (PDI AU) & Robex (RBX AU) Together Again

By David Blennerhassett

  • After Perseus Mining (PRU AU) fielded a scrip option for 17.8%-held Predictive Discovery (PDI AU), I questioned whether Robex Resources (RXR AU) would exercise its matching rights. I was wrong. 
  • Robex has “lifted its bid“, now 7.862 PDI for every Robex share. Under the revised Offer Robex will own 46.5% of the combined entity, down from 49%.
  • PDI considers the new terms to be superior to Perseus’ tilt. Apparently, so do several of PDI’s largest shareholders.  Perseus has now terminated its binding proposal. Out of the picture?

Meilan Airport (357 HK)’s SPA (Finally) Done. Now For The HK$10.62/Share MGO

By David Blennerhassett

  • Given the change of control into Meilan Airport (357 HK), was, in effect, a  re-arrangement of Meilan Airport shares under the same ultimate parent, the regulatory approval process curiously dragged.
  • Yesterday Meilan Airport announced all SPA conditions have now been satisfied, and that the SPA should complete in 20 business days. A Composite Doc will then be issued.
  • Trading almost at terms. This is a back-end proposition play. My peer basket is up 11%, on average, since the Offer was first announced. Asian peers are up 15%.

Meilan Airport (357 HK): SPA Precondition Satisfied, Setting up an Unconditional MGO at HK$10.62

By Arun George

  • On 30 April, Haikou Meilan International Airport entered a SPA with Hainan Airport Infrastructure (600515 CH) to sell its Hainan Meilan International Airport (357 HK) 50.19% stake at RMB9.85 (HK$10.62).
  • The SPA precondition is satisfied, and the SPA will be completed within 20 business days. Completion will trigger an unconditional MGO at HK$10.62.
  • Tendering is likely to be low as the offer is unattractive. At the last close and for a mid-February 2026 payment, the gross/annualised spread is 0.2%/1.1%.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief Consumer: Toyota Industries, Meesho, DraftKings , Toyota Motor, Gabriel India, Seven & I Holdings, Somnigroup International, DigiPlus Interactive , Advance Auto Parts, Renaissance Inc and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Toyota Industries (6201 JP): Elliott Ramps up the Pressure
  • The Beat Ideas: Meesho Ltd- Deciphering India’s Value-E-Commerce Giant
  • DraftKings Inc.: An Insight Into Regulatory Developments
  • Toyota Motor (7203 JP) Tactical Outlook: Undervalued and Rising
  • Primer: Gabriel India (GABR IN) – Dec 2025
  • Seven Eleven: Still a Work in Progress as Lawson and Familymart Innovate
  • SGI: An Inside Insight Into Tempur Sealy & Mattress Firm Synergies Driving Explosive Upside!
  • DigiPlus Interactive (PLUS PM) PSE Webinar Updates + Recent Acquisition – All Positives
  • Advance Auto Parts (AAP): Out of Gas
  • Primer: Renaissance Inc (2378 JP) – Dec 2025


Toyota Industries (6201 JP): Elliott Ramps up the Pressure

By Arun George

  • Elliott has filed a substantial shareholder notice reporting a Toyota Industries (6201 JP) ownership of 16.3 million or 5.01% of outstanding shares.
  • The disclosure is likely a tactic to pressure Toyota Fudosan (offeror) and also a useful signalling tactic to other minorities that Elliott is committed to securing a bump.
  • A potential bump could reach JPY19,000. While this would require an additional US$4 billion, financing should not be an issue as the book value (understated) is close to JPY18,000. 

The Beat Ideas: Meesho Ltd- Deciphering India’s Value-E-Commerce Giant

By Sudarshan Bhandari

  • Meesho successfully went  public with a Fresh Issue of up to INR4,250 crore. Notably, nearly 44% of the fresh capital is earmarked specifically for deepening its technology and AI moat.
  • Unlike traditional search-led e-commerce, Meesho is proving the viability of a “discovery-led” model powered by an immense data engine (5.9 billion daily data points), integrating a high-growth content commerce business. 
  • Meesho presents a compelling play on consumption. IPO is not just for funding growth, but for funding AI infrastructure required to defend its “Everyday Low Price” moat against deep-pocketed competitors.

DraftKings Inc.: An Insight Into Regulatory Developments

By Baptista Research

  • DraftKings Inc. recently held its third-quarter 2025 earnings call, highlighting both achievements and challenges.
  • The company reported $1.144 billion in revenue, growing 4% year-over-year, though this was below their expectations due to unfavorable sports outcomes impacting revenue by over $300 million.
  • Despite these challenges, some positive developments were noted.

Toyota Motor (7203 JP) Tactical Outlook: Undervalued and Rising

By Nico Rosti

  • On October 21st we published an insight predicting Toyota Motor’s imminent pullback. The stock started to pullback the following week, the correction lasted for a few weeks.
  • After last week’s weakness, Toyota Motor (7203 JP) is rallying again. There’s conflicting sentiment on valuation—some see it as undervalued.
  • This insight presents a short-term tactical analysis with a bullisht target at 3291 (75% probability of seeing a new pullback after that target is reached). 

Primer: Gabriel India (GABR IN) – Dec 2025

By αSK

  • Dominant Market Leader Poised for Diversified Growth: Gabriel India is the flagship company of the ANAND Group and a market leader in ride control products in India, with an 89% market share in the commercial vehicle segment, 32% in two/three-wheelers, and 24% in passenger vehicles. A recent strategic restructuring is set to transform the company from a suspension-focused entity into a diversified mobility solutions provider, integrating businesses in EV drivetrains, automotive fluids, NVH solutions, and sunroofs.
  • Strong Financial Performance and Growth Trajectory: The company has demonstrated a robust growth track record, with a 3-year revenue CAGR of 20.35% and a net income CAGR of 39.88%. This financial strength is underpinned by its leadership position, strong OEM relationships, and a vast aftermarket network of over 700 dealers and 12,000 retailers.
  • Strategic Pivot to High-Growth Areas: Gabriel is proactively adapting to industry trends by expanding into higher-growth segments. It has a first-mover advantage in the electric two-wheeler (E2W) space, commanding over 70% market share. Furthermore, new joint ventures for sunroofs and EV fluids position the company to capitalize on vehicle premiumization and electrification trends.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Seven Eleven: Still a Work in Progress as Lawson and Familymart Innovate

By Michael Causton

  • The convenience store sector is not only saturated but also facing serious levels of new competition. Despite this, Seven Eleven posted much higher growth in November but problems remain.
  • The big 3 are working hard to innovate their way out of trouble and move on to new, fertile pastures of growth but Seven Eleven is behind Lawson and Familymart.
  • Innovation means high levels of differentiation across prices, tech, services and merchandising, making each chain much more distinctive and a fascinating example of where Japanese retail is headed.

SGI: An Inside Insight Into Tempur Sealy & Mattress Firm Synergies Driving Explosive Upside!

By Baptista Research

  • Somnigroup International reported a strong performance in the third quarter of 2025, driven by its recent acquisition of Mattress Firm and successful execution of key initiatives.
  • The company achieved record results across important financial metrics despite flat conditions in the U.S. bedding market and persistent challenges internationally.
  • Net sales rose by 63% to $2.1 billion, while adjusted EBITDA increased 52% to $419 million, and adjusted EPS grew by 16% to $0.95 per share.

DigiPlus Interactive (PLUS PM) PSE Webinar Updates + Recent Acquisition – All Positives

By Sameer Taneja

  • DigiPlus Interactive (PLUS PM) confirmed that the government is working with licensed operators to develop a legal framework to ensure responsible gaming/root out illegal gambling/player protection—final hearing this month(December). 
  • The company purchased a convertible bond for 1.6 billion HKD (205 million USD), giving it the right to acquire 53.89% of International Entertainment (1009 HK), lowering its GGR share. 
  • The stock trades at 7x/5.5x FY25/26PE, based on our numbers, which assume a sequential quarterly recovery (normalized by Q2FY26 levels) as guided by management

Advance Auto Parts (AAP): Out of Gas

By J Capital Research

  • Advance Auto Parts (AAP) continues to struggle even after two major restructuring programs.
  • For 2025, this seller of after-market auto parts has pulled out a save from liquidity constraints by raising cash, extending debt maturities, shedding assets, and streamlining operations.
  • But that brings AAP near to the bottom of its bag of tricks.

Primer: Renaissance Inc (2378 JP) – Dec 2025

By αSK

  • Renaissance Inc. is a major player in the Japanese fitness industry, demonstrating a strong revenue recovery post-pandemic, although profitability and cash flow remain volatile.
  • The company is diversifying its business model beyond traditional fitness clubs to include healthcare-related services, such as corporate wellness programs and senior-focused rehabilitation centers, tapping into Japan’s key demographic trends.
  • While facing intense competition and economic sensitivity, the company’s strategic focus on health solutions for an aging population and its established brand presence of over 100 clubs position it for potential long-term growth in the expanding wellness market.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Macro: Platinum’s Year End Bull Run? // La Niña Update and more

By | Daily Briefs, Macro

In today’s briefing:

  • Platinum’s Year End Bull Run? // La Niña Update
  • Oil futures: Crude off lows as Venezuelan tanker seized by US
  • BoC: Structural Pause at 2.25%
  • Sri Lanka’s Rubber Exports Lose Grip as New Challenges Shape Outlook


Platinum’s Year End Bull Run? // La Niña Update

By The Commodity Report

  • Platinum continues to look strong, as does copper. Platinum tends to deliver above average returns during December and February, according to recent seasonal stats.
  • Over the last 25 years, platinum has produced an average return of +7.79% from December 6 to February 20, with a win rate of 84% and an annualized return of +43.29%, according to Seasonax. (we can verify this trend)
  • Copper on the other hand remains more of a tariff play.

Oil futures: Crude off lows as Venezuelan tanker seized by US

By Quantum Commodity Intelligence

  • Crude oil futures recovered from monthly lows Wednesday after reports that the US had seized a Venezuelan tanker, although fears over a massive surplus kept benchmarks at the low end of the December trading range.
  • Front-month Feb26 ICE Brent  futures were trading at  $62.67/b (2042 GMT) versus Tuesday’s settle of $61.94/b, while Jan26 NYMEX WTI  was at  $59.02/b against a previous close of $58.25/b.
  • Brent recovered from an intraday low $61.35/b after officials confirmed that the US Coast Guard had led an operation to seize the vessel carrying Venezuelan oil.

BoC: Structural Pause at 2.25%

By Heteronomics AI

  • The BoC held the policy rate at 2.25%, matching the consensus, and framed this as a pause near neutral that likely extends the horizon for stable rates.​
  • Strong but trade‑driven Q3 growth and still‑soft domestic demand argue against near‑term hikes, keeping the bias toward a prolonged hold rather than renewed easing.​
  • With CPI near 2% and core around 2.5%, the Bank sees inflation anchored, reducing pressure for further cuts and reinforcing a data‑dependent, higher‑for‑longer rate stance.​
This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.

Sri Lanka’s Rubber Exports Lose Grip as New Challenges Shape Outlook

By Vinod Nedumudy

Highlights

• Exports dip nearly 7% YoY in September due to weak tire shipments

• President firm on SVAT removal, raising liquidity concerns

• EUDR compliance becomes key export test in days to come

  • During the first nine months, total export earnings fell 5.97% to US$713.62 million, largely driven by a 16.3% drop in tire and tube shipments.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thailand: Asian Sea and more

By | Daily Briefs, Thailand

In today’s briefing:

  • Primer: Asian Sea (ASIAN TB) – Dec 2025


Primer: Asian Sea (ASIAN TB) – Dec 2025

By αSK

  • Asian Sea is a diversified food producer with four key segments: Frozen Food, Pet Food, Shelf-stable Human Food (Tuna), and Aquaculture Feed, leveraging over 60 years of experience.
  • The company exhibits strong shareholder returns, evidenced by a high dividend yield and a perfect 5/5 Smartkarma dividend score, supported by robust operating and free cash flow growth.
  • While long-term growth is impressive, the company has faced recent headwinds, reflected in negative 3-year net income and market cap compound annual growth rates (CAGR), alongside contracting margins in recent quarters.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Xrf Scientific, Bell Financial and more

By | Australia, Daily Briefs

In today’s briefing:

  • Primer: Xrf Scientific (XRF AU) – Dec 2025
  • Bell Financial Group Ltd – Boom times are back


Primer: Xrf Scientific (XRF AU) – Dec 2025

By αSK

  • Xrf Scientific is a manufacturer and distributor of scientific instruments, specialized chemicals, and precious metal products for the analytical and mining industries. The company’s core business revolves around providing a complete suite of products for sample preparation and analysis, primarily for X-ray fluorescence (XRF) and inductively coupled plasma (ICP) techniques.
  • The company operates through three main segments: Capital Equipment, Precious Metals, and Consumables. The Consumables segment, particularly the production of fusion flux, is a significant contributor to profits and boasts a dominant global market share. The Precious Metals division manufactures platinum-based labware, while the Capital Equipment segment produces furnaces and other laboratory instruments.
  • Xrf Scientific has demonstrated a strong growth trajectory, characterized by consistent revenue and profit growth over the past several years. This growth is supported by a diverse customer base that includes major mining companies and industrial clients, reducing its dependence on the cyclicality of the mining sector. The company has also pursued strategic acquisitions to expand its product offerings and market reach.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Bell Financial Group Ltd – Boom times are back

By RaaS Research Group (RaaS)

  • Bell Financial Group Ltd (ASX:BFG) is a diversified provider of financial products and software solutions within, and increasingly outside, its traditional full-service stockbroking business.
  • BFG has provided a trading update for the 11 months to November 2025, with group PBT well above RaaS estimates.
  • Technology & Platforms and Products & Services PBT combined was 24% above the previous corresponding period (pcp) (RaaS +15% for FY25), an acceleration on the H1 FY25 growth rate (+16%).

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Strategy, NVIDIA Corp, Medline, Andersen Group, DraftKings , Platinum, Seagate Technology Holdings PL, Somnigroup International, Cardinal Infrastructure, Virgin Galactic Holdings and more

By | Daily Briefs, United States

In today’s briefing:

  • Strategy (MSTR US)’s Bitcoin Premium Evaporates. And Then Some
  • Jensen Got What He Wanted And/Or Pres. Trump Needed a Sweetener for China
  • Medline Aims for a $5 Billion IPO as America’s Largest Privately Held Medical Supplier
  • Wall Street Takes a Hard Look at Andersen’s Next Act
  • DraftKings Inc.: An Insight Into Regulatory Developments
  • Platinum’s Year End Bull Run? // La Niña Update
  • Nasdaq100 December 2025 Forecast (Final): 12 Changes
  • SGI: An Inside Insight Into Tempur Sealy & Mattress Firm Synergies Driving Explosive Upside!
  • Cardinal Infrastructure Group (CDNL): CDNL Lays a Solid Foundation as IPO Opens Above Expectations
  • Primer: Virgin Galactic Holdings (SPCE US) – Dec 2025


Strategy (MSTR US)’s Bitcoin Premium Evaporates. And Then Some

By David Blennerhassett

  • Strategy (MSTR US)‘s market cap has for near-on five years, traded at a premium to its bitcoin holdings. 
  • The backbone of Strategy’s levered strategy is issue new shares or debt, acquire more bitcoins, which in turn, boost the share price. Rinse and repeat. Until the music stops.
  • That market cap is now at its widest discount in five years. And chairman Michael Saylor scandalously mooted the company may sell some bitcoins IF the discount persists.

Jensen Got What He Wanted And/Or Pres. Trump Needed a Sweetener for China

By Nicolas Baratte

  • Pres Trump authorized sales of H200 to China, with unknown conditions attached.  Not clear who the US will agree to sell to, who in China will be “allowed” to buy
  • More clear: H20 was not appealing – too under-powered. H200 is above the threshold at 2x the performance of Huawei Ascend 910C. So, Nvidia could find buyers in China.
  • H200 could represent 23% upside to Nvidia 2026 revenues (max). But the stock price moved up 1.7% on Monday, down -0.3% yesterday. The market is concerned by bigger issues.

Medline Aims for a $5 Billion IPO as America’s Largest Privately Held Medical Supplier

By IPO Prophet

  • Medline Inc., the Northfield, Illinois–based medical products manufacturer and distributor, is advancing toward one of 2025’s largest IPOs.
  • The company plans to raise $5.0 billion by offering 179 million Class A shares at a price range of $26–$30, with an expected listing on the Nasdaq Global Select Market under the ticker MDLN.
  • At the midpoint valuation of $28, Medline would command a fully diluted market capitalization of approximately $37.3 billion, positioning it among the year’s most significant offerings.

Wall Street Takes a Hard Look at Andersen’s Next Act

By IPO Prophet

  • Andersen Group Inc., a San Francisco–based tax and advisory firm, has set terms to raise approximately $165 million in its upcoming NYSE IPO by offering 11 million Class A shares priced in a range of $14–$16 per share.
  • At the midpoint, the deal implies a market capitalization of roughly $1.64 billion based on 109.3 million total shares outstanding after the offering.
  • The company will trade under the ticker ANDG, with Morgan Stanley, UBS Investment Bank, Deutsche Bank Securities, Truist, Wells Fargo, Baird, and William Blair leading the underwriting syndicate.

DraftKings Inc.: An Insight Into Regulatory Developments

By Baptista Research

  • DraftKings Inc. recently held its third-quarter 2025 earnings call, highlighting both achievements and challenges.
  • The company reported $1.144 billion in revenue, growing 4% year-over-year, though this was below their expectations due to unfavorable sports outcomes impacting revenue by over $300 million.
  • Despite these challenges, some positive developments were noted.

Platinum’s Year End Bull Run? // La Niña Update

By The Commodity Report

  • Platinum continues to look strong, as does copper. Platinum tends to deliver above average returns during December and February, according to recent seasonal stats.
  • Over the last 25 years, platinum has produced an average return of +7.79% from December 6 to February 20, with a win rate of 84% and an annualized return of +43.29%, according to Seasonax. (we can verify this trend)
  • Copper on the other hand remains more of a tariff play.

Nasdaq100 December 2025 Forecast (Final): 12 Changes

By Dimitris Ioannidis


SGI: An Inside Insight Into Tempur Sealy & Mattress Firm Synergies Driving Explosive Upside!

By Baptista Research

  • Somnigroup International reported a strong performance in the third quarter of 2025, driven by its recent acquisition of Mattress Firm and successful execution of key initiatives.
  • The company achieved record results across important financial metrics despite flat conditions in the U.S. bedding market and persistent challenges internationally.
  • Net sales rose by 63% to $2.1 billion, while adjusted EBITDA increased 52% to $419 million, and adjusted EPS grew by 16% to $0.95 per share.

Cardinal Infrastructure Group (CDNL): CDNL Lays a Solid Foundation as IPO Opens Above Expectations

By IPO Boutique

  • Cardinal Infrastructure debuted with a disciplined, well-supported IPO, opening 9.5% above pricing and finishing the session up nearly 12%.
  • Strong  demand—multiple-times oversubscribed with no price sensitivity—validated the company despite limited sector momentum.
  • Cardinal’s diversified, margin-expanding infrastructure platform and conservative leverage profile underpin long-term scalability and investor confidence.

Primer: Virgin Galactic Holdings (SPCE US) – Dec 2025

By αSK

  • Virgin Galactic is at a critical inflection point, pausing current commercial operations to focus resources on its next-generation Delta-class spaceships, which are paramount for achieving future scalability and profitability.
  • The company operates in a pre-profitability stage, characterized by significant cash burn and reliance on capital markets to fund development. Future success is entirely contingent on the successful and timely execution of the Delta program, slated for commercial service in 2026.
  • While holding a unique position in the nascent space tourism industry, SPCE faces considerable operational, financial, and market risks. The valuation is speculative, reflecting a high-risk, high-reward bet on the future of commercial spaceflight.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: SK Square , SeAH Besteel Holdings, Nice Information Service Co, Daihan Pharmaceutical, E Credible, E World and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Hynix & Square L2 Flags Set to Squeeze Spread Near Term
  • Korea Small Cap Gem #50: Seah Besteel Holdings – A Potential Beneficiary of SpaceX IPO
  • Primer: Nice Information Service Co (030190 KS) – Dec 2025
  • Primer: Daihan Pharmaceutical (023910 KS) – Dec 2025
  • Primer: E Credible (092130 KS) – Dec 2025
  • Primer: E World (084680 KS) – Dec 2025


Hynix & Square L2 Flags Set to Squeeze Spread Near Term

By Sanghyun Park

  • SK Hynix and SK Square hit L2 flags; cash-only until Dec 24. Margin off, >40% two-day rip triggers halt. L2 lifts if below T-5/+45%, T-15/+75%, and 15-day high.
  • L2’s usually a non-event, but this time the margin freeze probably smacks Hynix harder. Key trigger is staying below the 15-day high: Hynix ₩587,000, Square ₩324,000.
  • Govt set to roll out AI-semiconductor holdco deregulation this week, boosting AI holdcos like Square and juicing a near-term Square-over-Hynix trade opportunity.

Korea Small Cap Gem #50: Seah Besteel Holdings – A Potential Beneficiary of SpaceX IPO

By Douglas Kim

  • In 2026, one of the emerging investment themes will likely be the main value-chain suppliers to SpaceX which is gearing up for a huge IPO next year.
  • Seah Besteel Holdings is expected to be one of the specialty steel suppliers to SpaceX. Seah is investing about US$155 million to build a special alloy plant in the US.
  • In addition to SpaceX, Seah Besteel Holdings plans to gain additional major US customers including Boeing Co (BA US), Lockheed Martin (LMT US), GE Aerospace, and Pratt & Whitney.

Primer: Nice Information Service Co (030190 KS) – Dec 2025

By αSK

  • Dominant Market Leader in a High-Barrier Industry: NICE Information Service is the largest credit bureau in South Korea, an industry characterized by significant regulatory hurdles and network effects, affording it a strong competitive moat.
  • Consistent Financial Performance and Shareholder Returns: The company has demonstrated a solid track record of revenue, net income, and EPS growth over the past decade, complemented by a consistent and growing dividend payout to shareholders.
  • Attractive Valuation Relative to Global Peers: NICE trades at a significant valuation discount to its international counterparts like Transunion and Equifax, presenting a potential value opportunity for investors, contingent on its ability to sustain growth and profitability.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Daihan Pharmaceutical (023910 KS) – Dec 2025

By αSK

  • Dominant Niche Player with Strong Growth: Daihan Pharmaceutical is a leading manufacturer of intravenous (IV) solutions in South Korea, a market poised for steady growth driven by an aging population and increasing healthcare needs. The company has demonstrated a solid track record of revenue and net income growth, outpacing its negative market capitalization trend.
  • Exceptional Shareholder Returns and Value Proposition: The company exhibits a robust dividend profile, with a strong yield and a 5-year dividend CAGR of over 17%. Valuation analysis reveals a significant discount compared to peers across key metrics like P/E, P/B, and EV/Sales, suggesting a potentially attractive entry point for value-oriented investors.
  • Favorable Industry Tailwinds: The South Korean pharmaceutical market is projected to experience robust growth, with the intravenous solutions segment expected to expand at a CAGR of approximately 8.7% through 2030. This provides a supportive macro environment for Daihan’s core business operations.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: E Credible (092130 KS) – Dec 2025

By αSK

  • E Credible is a dominant player in the niche market of corporate credit certification in South Korea, providing essential credit risk information on SMEs to large corporate clients for supply chain management.
  • The company is poised to benefit from the growing trend of ESG (Environmental, Social, and Governance) integration in supply chains, having proactively developed ESG evaluation services for SMEs, which presents a significant long-term growth driver.
  • Despite a challenging recent growth track record and sensitivity to economic cycles, the company maintains a strong financial position with a high net cash balance, a low-capex model, and a commitment to high dividend payouts, offering an attractive yield.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: E World (084680 KS) – Dec 2025

By αSK

  • E World is a regional theme park operator in Daegu, South Korea, centered around its landmark 83 Tower. The company is facing severe financial headwinds, characterized by declining revenues, significant and widening net losses, and negative operating cash flows over the past three years.
  • The company’s valuation presents a mixed picture. While traditional earnings-based metrics are meaningless due to losses, its Price-to-Book ratio is comparable to peers, suggesting a potential valuation floor based on its physical assets. The Smartkarma ‘Value’ score of 4/5 supports this view.
  • The outlook is heavily dependent on a successful operational turnaround and a broader recovery in the regional tourism market. While the South Korean tourism industry shows strong growth prospects, E World‘s ability to capitalize on this trend remains uncertain given its deteriorating financial performance and intense competition.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars